Similar articles

• [H2 blockers in the treatment of bleeding gastroduodenal ulcers].

  Nikiforov PA, Bazarova MA, Nikitina SA, Osin VL, Shugurov VA. Nikiforov PA, et al. Khirurgiia (Mosk). 2001;(10):49-50. Khirurgiia (Mosk). 2001. PMID: 11763821 Russian. No abstract available.
• Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?

  Fiorucci S, Clausi GG, Farinelli M, Santucci L, Farroni F, Pelli MA, Morelli A. Fiorucci S, et al. Am J Gastroenterol. 1988 Dec;83(12):1371-5. Am J Gastroenterol. 1988. PMID: 2904218 Clinical Trial.
• Famotidine in the USA: a review of efficacy studies.

  Gitnick G. Gitnick G. J Int Med Res. 1989;17 Suppl 1:17A-24A. J Int Med Res. 1989. PMID: 2566539 Review.
• Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.

  Chen PH, Wang TH, Wang CY, Chen CY, Cheng TC, Tsai YT, Siauw CP, Yang KC, Chen GH, Sung JL. Chen PH, et al. J Int Med Res. 1989;17 Suppl 1:25A-31A. J Int Med Res. 1989. PMID: 2566541 Clinical Trial.
• [High demands on drug administration and pharmacological principles applied in ulcer diseases].

  Hellström PM. Hellström PM. Lakartidningen. 1991 Feb 6;88(6):425-30. Lakartidningen. 1991. PMID: 1671887 Review. Swedish. No abstract available.